Xonefit-T 1.125 Injection
Marketer
Medizia Biotech
Salt Composition
Ceftriaxone (1000mg) + Tazobactum (125mg)
Overview Xonefit-T 1.125 Injection
Xonefit-T 1.125 Injection, a multi-component medication, combats diverse bacterial infections. Its action inhibits microbial proliferation, thus limiting infection spread. Administration must always be overseen by a qualified medical practitioner. Consistent adherence to the prescribed dosage schedule is crucial; prematurely halting treatment compromises its effectiveness. Typical side effects include nausea, vomiting, diarrhea, and dyspepsia. Any worsening symptoms necessitate immediate medical consultation. Seek prompt medical attention for allergic reactions (e.g., rash, pruritus, edema, dyspnea). Inform your physician of all concurrent medications before commencing treatment. Pregnant or lactating individuals require prior medical counsel. Alcohol consumption should be avoided due to potential increased drowsiness. While typically non-impairing to driving ability, refrain from driving if drowsiness or dizziness occur. Adequate rest, a nutritious diet, and sufficient hydration are recommended for optimal recovery. Your doctor may order lab tests to monitor the medicine's effects.
Uses of Xonefit-T 1.125 Injection
Infections caused by bacteria
Major Benefits of Xonefit-T 1.125 Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Xonefit-T 1.125 Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Xonefit-T 1.125 Injection:
This medication will be administered by your physician or their designated nurse. Self-medication is strictly prohibited.
How Xonefit-T 1.125 Injection works:
Xonefit-T 1.125 Injection merges Ceftriaxone, a bacterial growth inhibitor, with Tazobactum, a beta-lactamase inhibitor. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, vital for bacterial viability. Tazobactum complements this by countering bacterial resistance mechanisms, thereby boosting Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concomitant use of alcohol and Xonefit-T 1.125 Injection.
PregnancySAFE IF PRESCRIBED
The injectable medication Xonefit-T 1.125 is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no harm to the fetus; nevertheless, clinical data from human trials remain scarce.
Breast feedingCAUTION
Administration of Xonefit-T 1.125 Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administration of Xonefit-T 1.125 Injection may induce drowsiness, blurred vision, and dizziness, potentially impairing alertness. Driving should be avoided if these effects manifest.
KidneyCONSULT YOUR DOCTOR
Data regarding Xonefit-T 1.125 Injection use in individuals with renal impairment is scarce. Physician consultation is advised.
LiverCAUTION
Administering Xonefit-T 1.125 Injection requires careful consideration in individuals with advanced hepatic impairment. Dosage modification for Xonefit-T 1.125 Injection might be necessary; physician consultation is advised. Altering the Xonefit-T 1.125 Injection dosage is generally not suggested for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Xonefit-T 1.125 Injection :
Omit a scheduled Xonefit-T 1.125 Injection? Seek medical advice immediately.
Facts to Know About Xonefit-T 1.125 Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Anti-Infective Agents |
3,018 People bought this recently